N-Nitroso Chloroquine Impurity
Specifications
Product name
N-Nitroso Chloroquine Impurity
SRC CAT No
SRC-N014473
CAS No
NA
Mol.F.
C18H25ClN4O
Mol.Wt.
348.9
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(7-Chloroquinolin-4-yl)-N-(5-(diethylamino)pentan-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Chloroquine phosphate is used to prevent and treat malaria. It is also used to treat amebiasis. Chloroquine phosphate is in a class of drugs called antimalarials and amebicides. It works by killing the organisms that cause malaria and amebiasis.
N-Nitroso Chloroquine chemically represented as N-(7-Chloroquinolin-4-yl)-N-(5-(diethylamino)pentan-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Chloroquine . We supply N-Nitroso Chloroquine with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
Tofacitinib Nitroso Impurity 10
| CAT No | SRC-N0143712 |
| CAS No | NA |
| Mol.F. | C13H20N6O |
| Mol.Wt. | 276.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso 2-Propionyl Phenothiazine
| CAT No | SRC-N0143713 |
| CAS No | NA |
| Mol.F. | C15H12N2O2S |
| Mol.Wt. | 284.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Dimer Impurity 2
| CAT No | SRC-N0143714 |
| CAS No | NA |
| Mol.F. | C52H57N15O4 |
| Mol.Wt. | 956.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 1
| CAT No | SRC-N0143715 |
| CAS No | NA |
| Mol.F. | C15H15ClN6O5 |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 2
| CAT No | SRC-N0143716 |
| CAS No | NA |
| Mol.F. | C25H22N8O6 |
| Mol.Wt. | 530.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 3
| CAT No | SRC-N0143717 |
| CAS No | NA |
| Mol.F. | C27H29N9O5 |
| Mol.Wt. | 559.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 4
| CAT No | SRC-N0143718 |
| CAS No | NA |
| Mol.F. | C27H31N9O3 |
| Mol.Wt. | 529.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 5
| CAT No | SRC-N0143719 |
| CAS No | NA |
| Mol.F. | C26H27N9O5 |
| Mol.Wt. | 545.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Lazertinib Nitroso Impurity 6
| CAT No | SRC-N0143720 |
| CAS No | NA |
| Mol.F. | C26H29N9O3 |
| Mol.Wt. | 515.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lazertinib
| CAT No | SRC-N0143721 |
| CAS No | NA |
| Mol.F. | C30H33N9O4 |
| Mol.Wt. | 583.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso N-Desmethyl Lazertinib
| CAT No | SRC-N0143722 |
| CAS No | NA |
| Mol.F. | C29H31N9O4 |
| Mol.Wt. | 569.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Phenoxymethylpenicillin EP Impurity E
| CAT No | SRC-N0143723 |
| CAS No | NA |
| Mol.F. | C16H19N3O7S |
| Mol.Wt. | 397.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |